CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonist. (2014)

First Author: Sarvi S

Attributed to: MRC Centre for Regenerative Medicine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/0008-5472.can-13-1541

PubMed Identifier: 24436149

Publication URI: http://europepmc.org/abstract/MED/24436149

Type: Journal Article/Review

Volume: 74

Parent Publication: Cancer research

Issue: 5

ISSN: 0008-5472